RDTI for Biotech and Life Sciences
Biotech and life sciences companies are among the most significant beneficiaries of the R&D Tax Incentive. Drug development, clinical trials, medical device innovation, and diagnostic platform development typically involve extensive eligible R&D activities.
Supporting Complex Claims
Life sciences R&D is often complex, spanning multiple financial years and involving substantial expenditure. ExaRDTI manages this complexity by tracking activities and costs across projects and periods. You work with your RDTI specialist and the AI platform to build documentation that clearly articulates the scientific hypotheses, experimental methodologies, and outcomes for each activity.
Common Eligible Activities
Biotech companies frequently claim for drug discovery and development, clinical trial design and execution, medical device prototyping and testing, diagnostic assay development, bioinformatics and computational biology, and regulatory science innovation. ExaRDTI’s AI drafts technical narratives tailored to life sciences terminology, which you and your RDTI specialist refine to meet AusIndustry expectations for this sector.
Maximising Life Sciences Claims
With R&D expenditure often running into millions of dollars, accurate capture and apportionment is critical. ExaRDTI helps identify and allocate eligible costs — including laboratory staff, consumables, CRO fees, and specialised equipment — with the aim of correct allocation and substantiation.
Start Your Claim
Book a free 30-minute consultation to discuss your biotech or life sciences R&D activities and estimate your potential claim.